Pancreas preservation with University of Wisconsin and celsior solutions: A single-center, prospective, randomized pilot study

Ugo Boggi, Fabio Vistoli, Marco Del Chiaro, Stefano Signori, Chiara Croce, Andrea Pietrabissa, Raffaella Berchiolli, Piero Marchetti, Stefano Del Prato, Franco Mosca

Research output: Contribution to journalArticle

Abstract

Background. Celsior is an extracellular-type, low-viscosity, preservation solution already used for heart, lung, liver, and kidney transplantation. We report the results of a single-center, prospective, randomized pilot study specifically designed to compare the safety profile of Celsior solution with University of Wisconsin (UW) solution in clinical pancreas transplantation. Methods. A total of 105 consecutive procurements were randomized to graft preservation with UW (n=53) solution or Celsior (n=52) solution. The groups were comparable with regard to all donor and recipient characteristics. Results. Five grafts were discarded and 100 grafts (50 UW vs. 50 Celsior) were transplanted. Mean cold and warm ischemia times were 11.0±2.1 hr and 37.2±6.0 min for UW compared with 10.8±1.8 hr and 38.1±5.9 min for Celsior (P=not significant). Delayed endocrine pancreas function was recorded in one graft preserved with UW solution. Eleven recipients (UW 12% vs. Celsior 10%, P=not significant) required a relaparotomy. The mean serum levels of glucose, amylase, and lipase remained comparable between the study arms at equivalent intervals after transplantation. One recipient died with functioning grafts in each study arm; two further grafts were lost to arterial thrombosis (Celsior) and chronic rejection (UW), respectively. Actuarial 1-year patient and graft survival rates overlapped in the two study arms (98% and 96%, respectively). Conclusions. Within the range of cold ischemia time reported in this study, UW and Celsior solutions have similar safety profiles for pancreas preservation.

Original languageEnglish
Pages (from-to)1186-1190
Number of pages5
JournalTransplantation
Volume77
Issue number8
Publication statusPublished - Apr 27 2004

Fingerprint

Pancreas
Transplants
Cold Ischemia
Arm
Heart-Lung Transplantation
Safety
Warm Ischemia
Pancreas Transplantation
Celsior
Graft Survival
Amylases
Lipase
Islets of Langerhans
Viscosity
Liver Transplantation
Kidney Transplantation
Thrombosis
Survival Rate
Transplantation
Tissue Donors

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Boggi, U., Vistoli, F., Del Chiaro, M., Signori, S., Croce, C., Pietrabissa, A., ... Mosca, F. (2004). Pancreas preservation with University of Wisconsin and celsior solutions: A single-center, prospective, randomized pilot study. Transplantation, 77(8), 1186-1190.

Pancreas preservation with University of Wisconsin and celsior solutions : A single-center, prospective, randomized pilot study. / Boggi, Ugo; Vistoli, Fabio; Del Chiaro, Marco; Signori, Stefano; Croce, Chiara; Pietrabissa, Andrea; Berchiolli, Raffaella; Marchetti, Piero; Del Prato, Stefano; Mosca, Franco.

In: Transplantation, Vol. 77, No. 8, 27.04.2004, p. 1186-1190.

Research output: Contribution to journalArticle

Boggi, U, Vistoli, F, Del Chiaro, M, Signori, S, Croce, C, Pietrabissa, A, Berchiolli, R, Marchetti, P, Del Prato, S & Mosca, F 2004, 'Pancreas preservation with University of Wisconsin and celsior solutions: A single-center, prospective, randomized pilot study', Transplantation, vol. 77, no. 8, pp. 1186-1190.
Boggi, Ugo ; Vistoli, Fabio ; Del Chiaro, Marco ; Signori, Stefano ; Croce, Chiara ; Pietrabissa, Andrea ; Berchiolli, Raffaella ; Marchetti, Piero ; Del Prato, Stefano ; Mosca, Franco. / Pancreas preservation with University of Wisconsin and celsior solutions : A single-center, prospective, randomized pilot study. In: Transplantation. 2004 ; Vol. 77, No. 8. pp. 1186-1190.
@article{37cdb46e5b24468d92646022b12ccc46,
title = "Pancreas preservation with University of Wisconsin and celsior solutions: A single-center, prospective, randomized pilot study",
abstract = "Background. Celsior is an extracellular-type, low-viscosity, preservation solution already used for heart, lung, liver, and kidney transplantation. We report the results of a single-center, prospective, randomized pilot study specifically designed to compare the safety profile of Celsior solution with University of Wisconsin (UW) solution in clinical pancreas transplantation. Methods. A total of 105 consecutive procurements were randomized to graft preservation with UW (n=53) solution or Celsior (n=52) solution. The groups were comparable with regard to all donor and recipient characteristics. Results. Five grafts were discarded and 100 grafts (50 UW vs. 50 Celsior) were transplanted. Mean cold and warm ischemia times were 11.0±2.1 hr and 37.2±6.0 min for UW compared with 10.8±1.8 hr and 38.1±5.9 min for Celsior (P=not significant). Delayed endocrine pancreas function was recorded in one graft preserved with UW solution. Eleven recipients (UW 12{\%} vs. Celsior 10{\%}, P=not significant) required a relaparotomy. The mean serum levels of glucose, amylase, and lipase remained comparable between the study arms at equivalent intervals after transplantation. One recipient died with functioning grafts in each study arm; two further grafts were lost to arterial thrombosis (Celsior) and chronic rejection (UW), respectively. Actuarial 1-year patient and graft survival rates overlapped in the two study arms (98{\%} and 96{\%}, respectively). Conclusions. Within the range of cold ischemia time reported in this study, UW and Celsior solutions have similar safety profiles for pancreas preservation.",
author = "Ugo Boggi and Fabio Vistoli and {Del Chiaro}, Marco and Stefano Signori and Chiara Croce and Andrea Pietrabissa and Raffaella Berchiolli and Piero Marchetti and {Del Prato}, Stefano and Franco Mosca",
year = "2004",
month = "4",
day = "27",
language = "English",
volume = "77",
pages = "1186--1190",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Pancreas preservation with University of Wisconsin and celsior solutions

T2 - A single-center, prospective, randomized pilot study

AU - Boggi, Ugo

AU - Vistoli, Fabio

AU - Del Chiaro, Marco

AU - Signori, Stefano

AU - Croce, Chiara

AU - Pietrabissa, Andrea

AU - Berchiolli, Raffaella

AU - Marchetti, Piero

AU - Del Prato, Stefano

AU - Mosca, Franco

PY - 2004/4/27

Y1 - 2004/4/27

N2 - Background. Celsior is an extracellular-type, low-viscosity, preservation solution already used for heart, lung, liver, and kidney transplantation. We report the results of a single-center, prospective, randomized pilot study specifically designed to compare the safety profile of Celsior solution with University of Wisconsin (UW) solution in clinical pancreas transplantation. Methods. A total of 105 consecutive procurements were randomized to graft preservation with UW (n=53) solution or Celsior (n=52) solution. The groups were comparable with regard to all donor and recipient characteristics. Results. Five grafts were discarded and 100 grafts (50 UW vs. 50 Celsior) were transplanted. Mean cold and warm ischemia times were 11.0±2.1 hr and 37.2±6.0 min for UW compared with 10.8±1.8 hr and 38.1±5.9 min for Celsior (P=not significant). Delayed endocrine pancreas function was recorded in one graft preserved with UW solution. Eleven recipients (UW 12% vs. Celsior 10%, P=not significant) required a relaparotomy. The mean serum levels of glucose, amylase, and lipase remained comparable between the study arms at equivalent intervals after transplantation. One recipient died with functioning grafts in each study arm; two further grafts were lost to arterial thrombosis (Celsior) and chronic rejection (UW), respectively. Actuarial 1-year patient and graft survival rates overlapped in the two study arms (98% and 96%, respectively). Conclusions. Within the range of cold ischemia time reported in this study, UW and Celsior solutions have similar safety profiles for pancreas preservation.

AB - Background. Celsior is an extracellular-type, low-viscosity, preservation solution already used for heart, lung, liver, and kidney transplantation. We report the results of a single-center, prospective, randomized pilot study specifically designed to compare the safety profile of Celsior solution with University of Wisconsin (UW) solution in clinical pancreas transplantation. Methods. A total of 105 consecutive procurements were randomized to graft preservation with UW (n=53) solution or Celsior (n=52) solution. The groups were comparable with regard to all donor and recipient characteristics. Results. Five grafts were discarded and 100 grafts (50 UW vs. 50 Celsior) were transplanted. Mean cold and warm ischemia times were 11.0±2.1 hr and 37.2±6.0 min for UW compared with 10.8±1.8 hr and 38.1±5.9 min for Celsior (P=not significant). Delayed endocrine pancreas function was recorded in one graft preserved with UW solution. Eleven recipients (UW 12% vs. Celsior 10%, P=not significant) required a relaparotomy. The mean serum levels of glucose, amylase, and lipase remained comparable between the study arms at equivalent intervals after transplantation. One recipient died with functioning grafts in each study arm; two further grafts were lost to arterial thrombosis (Celsior) and chronic rejection (UW), respectively. Actuarial 1-year patient and graft survival rates overlapped in the two study arms (98% and 96%, respectively). Conclusions. Within the range of cold ischemia time reported in this study, UW and Celsior solutions have similar safety profiles for pancreas preservation.

UR - http://www.scopus.com/inward/record.url?scp=2342523325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342523325&partnerID=8YFLogxK

M3 - Article

C2 - 15114082

AN - SCOPUS:2342523325

VL - 77

SP - 1186

EP - 1190

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 8

ER -